Medanta Q3: Profit Jumps 15% to Rs 143 Cr on Strong Revenue

Medanta Q3 Results: Net Profit Surges 15% to Rs 143 Crore

Strong Performance Driven by Increased Revenue and Patient Volume

Global Health, operating under the Medanta brand, has announced a robust financial performance for the third quarter of fiscal year 2025. The company reported a **15% year-on-year (YoY) increase in net profit, reaching Rs 143 crore**. This growth is attributed to a rise in revenue generated from new hospital facilities and an increase in overall patient volume, including a notable contribution from international patients.

In the corresponding quarter of the previous year, Medanta's net profit stood at Rs 123.5 crore. The latest results also reflect a **9% increase in net profit on a quarter-on-quarter (QoQ) basis**.

Revenue Growth and EBITDA Performance

Medanta's revenue for Q3FY25 witnessed a significant **12.8% YoY increase, totaling Rs 943.4 crore**. The company's earnings before interest, tax, depreciation, and amortization (EBITDA) also saw positive movement, rising by **8.4% YoY to Rs 253.8 crore**.

While EBITDA margins experienced a slight contraction of 94 basis points YoY to 26.5%, there was a sequential improvement of 120 basis points compared to the previous quarter. This reflects improved operational efficiencies and cost management.

Expansion Plans: Ranchi Hospital

Looking ahead, Medanta is set to expand its presence in Ranchi with the addition of a new 110-bedded hospital. This new facility, secured under a long-term lease agreement and strategically located near the existing Medanta Ranchi hospital, is expected to commence operations by the end of Q1FY26. This expansion underscores Medanta's commitment to providing quality healthcare services across India.

Operational Metrics

Key operational metrics also demonstrated positive trends:

• Average occupied bed days increased by 10.5% y-o-y.
• Overall occupancy rate reached 63.6%, reflecting increased bed capacity utilization.
• In-patient count rose by 12.9% y-o-y.
• Out-patient count increased by 8.7% y-o-y.

In summary, Medanta's Q3 results highlight a period of strong financial and operational performance, driven by strategic expansion, increased patient volume, and efficient management. The company's continued focus on delivering quality healthcare services positions it well for future growth.

Disclaimer: The views and investment tips expressed in this article are for informational purposes only and do not represent financial advice. The views expressed are those of the sources cited and not necessarily those of this website or its management. Investing in equities or other financial instruments carries the risk of financial loss. Readers must exercise due caution and conduct their own research before making any investment decisions. We are not liable for any losses incurred as a result of decisions made based on this article. Please consult a qualified financial advisor before making any investment.